Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 10/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 9/20 | 0.35 |
| ▸ | DRD2 | P14416 | 2/20 | 0.33 |
| ▸ | DRD3 | P35462 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | PER2 | O15055 | 1/20 | 0.32 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.31 |
| ▸ | FPR2 | P25090 | 2/20 | 0.31 |
| ▸ | TNF | P01375 | 1/20 | 0.30 |
| ▸ | IL1B | P01584 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.30 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.30 |
| ▸ | FPR1 | P21462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31068194 | 1.00 | CRBN (0.35) | CRBNDDB1DRD2DRD3KCNH2 | |
| SCHEMBL29348959 | 0.88 | CRBN (0.35) | CRBNDDB1DRD2DRD3KCNH2 | |
| SCHEMBL31068221 | 0.88 | CRBN (0.35) | CRBNDDB1DRD2DRD3KCNH2 | |
| SCHEMBL29348472 | 0.84 | CRBN (0.43) | CRBNDDB1 | |
| SCHEMBL31068143 | 0.83 | CRBN (0.35) | CRBNDDB1IKZF3 | |
| SCHEMBL29348984 | 0.83 | CRBN (0.35) | CRBNDDB1IKZF3 | |
| SCHEMBL29348393 | 0.81 | CNR2 (0.42) | CRBNDDB1TNFIL1BTBXA2R | |
| SCHEMBL29348543 | 0.81 | DDB1 (0.40) | CRBNDDB1FPR2TNFIL1B | |
| SCHEMBL29348285 | 0.81 | DDB1 (0.41) | CRBNDDB1TNFIL1BTBXA2R | |
| SCHEMBL29348424 | 0.80 | CRBN (0.45) | CRBNDDB1IKZF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151547-A1 | TARGETED DEGRADATION OF VAV1 | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |